FrancophonIA/ELRC3.0 huggingface dataset:
English: • Gently squeeze the dropper to release one drop of Cystadrops at a time.
Slovenian: • Previdno stisnite kapalko, da sprostite samo eno kapljico zdravila Cystadrops.
English: Although no effects during pregnancy and breast-feeding are anticipated, since systemic exposure to cysteamine is negligible, precautions should be taken with concomitant treatment with oral cysteamine.
Slovenian: Ker je sistemska izpostavljenost cisteaminu zanemarljiva, učinkov med nosečnostjo in dojenjem ne pričakujemo, vendar moramo uvesti previdnostne ukrepe pri sočasnem zdravljenju s peroralnim cisteaminom.
English: Pregnancy and breast-feeding Even if the level of Cystadrops in the blood is negligible, precautions should be taken.
Slovenian: Čeprav je raven zdravila Cystadrops v krvi zanemarljiva, morate upoštevati previdnostne ukrepe.
English: After first opening, the patient should be told to keep the dropper bottle at room temperature.
Slovenian: Bolniku je treba povedati, naj po prvem odprtju shranjuje kapalno steklenico pri sobni temperaturi.
English: If you put too many drops in your eyes, rinse your eyes out, preferably with saline solution (or if not available with warm water).
Slovenian: Če ste uporabili večji odmerek zdravila Cystadrops, kot bi smeli Če ste v oči vkapali preveč kapljic, sperite oči, po možnosti s fiziološko raztopino (če ta ni na voljo, jih sperite s toplo vodo).
English: After first opening: keep the dropper bottle tightly closed in the outer carton in order to protect from light.
Slovenian: Po prvem odprtju: kapalno steklenico shranjujte tesno zaprto v zunanji ovojnini za zagotovitev zaščite pred svetlobo.
English: Benzalkonium chloride is known to discolour soft contact lenses.
Slovenian: Za benzalkonijev klorid je znano, da spremeni barvo mehkih kontaktnih leč.
English: After first opening:
Slovenian: Po prvem odprtju:
English: How to store Cystadrops 6.
Slovenian: Shranjevanje zdravila Cystadrops 6.
English: • pain where the drops have been instilled
Slovenian: • bolečina na mestu vkapanja,
English: The recommended total daily ocular dose of cysteamine is no more than approximately 0.4% of the highest recommended dose of oral cysteamine in any age group.
Slovenian: Priporočeni skupni dnevni okularni odmerek cisteamina ni večji od približno 0,4 % največjega priporočenega peroralnega odmerka cisteamina v kateri koli starostni skupini.
English: One mL of eye drops solution contains 3.8 mg of cysteamine.
Slovenian: En ml raztopine kapljic za oko vsebuje 3,8 mg cisteamina.
English: Before first opening:
Slovenian: Pred prvim odprtjem:
English: Very common : eye pain, vision blurred, eye irritation, ocular hyperaemia, eye pruritus, lacrimation increased, deposit eye
Slovenian: Zelo pogosti: bolečine v očeh, zamegljen vid, draženje oči, okularna hiperemija, srbenje v očeh, povečano solzenje, depoziti v očeh
English: What Cystadrops contains - The active substance is cysteamine (mercaptamine), as hydrochloride.
Slovenian: Kaj vsebuje zdravilo Cystadrops - Učinkovina je cisteamin (merkaptamin) v obliki cisteaminijevega klorida.
English: Wait for your next scheduled application and then continue with your regular routine.
Slovenian: Če ste pozabili uporabiti zdravilo Cystadrops Počakajte na naslednji predvideni čas uporabe in nato nadaljujte z redno uporabo.
English: The accumulation of corneal cystine crystals increases if Cystadrops is discontinued.
Slovenian: Če uporabo zdravila Cystadrops prekinemo, se kopičenje cistinskih kristalov v roženici poveča.
English: • Discard 7 days after opening.
Slovenian: • Zavrzite 7 dni po odprtju.
English: How to use Cystadrops
Slovenian: Kako uporabljati zdravilo Cystadrops
English: • To avoid sticky eyes in the morning, it is recommended to apply the last drop of the day at least 30
Slovenian: • Jutranjo lepljivost oči lahko preprečite z vkapanjem zadnje dnevne kapljice vsaj 30 minut pred spanjem.
English: The following adverse reactions were reported during clinical trials and the French NPU programme with Cystadrops.
Slovenian: V kliničnih preskušanjih in francoskem programu sočutne uporabe (NPU) z zdravilom Cystadrops so poročali o naslednjih neželenih učinkih.
English: Each mL contains mercaptamine hydrochloride equivalent to 3.8 mg mercaptamine (cysteamine).
Slovenian: En ml vsebuje merkaptaminijev klorid, ki ustreza 3,8 mg merkaptamina (cisteamina).
English: Carmellose sodium Citric acid monohydrate Sodium hydroxide (for pH adjustment) Hydrochloric acid (for pH adjustment) Water for injections
Slovenian: 6.1 Seznam pomožnih snovi benzalkonijev klorid dinatrijev edetat natrijev karmelozat citronska kislina monohidrat natrijev hidroksid (za uravnavanje vrednosti pH) klorovodikova kislina (za uravnavanje vrednosti pH) voda za injekcije
English: Discard 7 days after first opening.
Slovenian: Zavrzite 7 dni po prvem odprtju.
English: A trend towards a lower IVCM total score in Cystadrops arm was observed at day 30.
Slovenian: Po 30 dneh so ugotovili trend k nižji skupni oceni IVCM v skupini preiskovancev, ki so prejemali zdravilo Cystadrops.
English: If you are worried, talk to your doctor or pharmacist.
Slovenian: Če ste negotovi, se posvetujte z zdravnikom ali farmacevtom.
English: Each mL of eye drops solution contains 0.1 mg of benzalkonium chloride.
Slovenian: Pomožna snov z znanim učinkom: En ml kapljice za oko, raztopina, vsebuje 0,1 mg benzalkonijevega klorida.
English: • The recommended interval between each application is 4 hours (for example, you can have your eye drops at 8.00 am, 12.00 am, 4.00 pm and 8.00 pm).
Slovenian: • Priporočeni časovni presledek med vsakim vkapanjem je 4 ure (npr. kapljice lahko uporabite ob
English: The mean decrease by 40% in the Cystadrops arm was confirmed at day 90.
Slovenian: Po 90 dneh so v skupini preiskovancev, ki so prejemali zdravilo Cystadrops, ugotovili povprečno zmanjšanje za 40 %.
English: Before the first admnistration, in order to facilitate the administration, the patient should be told to bring back Cystadrops at room temperature.
Slovenian: Pred prvo uporabo je treba bolniku povedati, naj počaka, da se zdravilo Cystadrops segreje na sobno temperaturo, da olajšajo uporabo.
English: Viscous, clear solution.
Slovenian: Viskozna, bistra raztopina.
English: Each mL contains 3.8 mg of cysteamine (mercaptamine), as hydrochloride.
Slovenian: En ml vsebuje 3,8 mg cisteamina (merkaptamina) v obliki cisteaminijevega klorida.
English: Cysteamine excretion in human's milk is unknown.
Slovenian: Ni znano, ali se cisteamin izloča v materino mleko.
English: • discomfort where the drops have been instilled (mainly sticky eyes and sticky eyelashes),
Slovenian: • nelagodje na mestu vkapanja (zlasti lepljive oči in lepljive trepalnice), ostanki zdravila na trepalnicah, okoli oči.
English: • Cystadrops must be brought back at room temperature before the first administration.
Slovenian: • Pred prvo uporabo morate počakati, da se zdravilo Cystadrops segreje na sobno temperaturo.
English: • Keep the dropper bottle tightly closed in the outer carton in order to protect from light.
Slovenian: • Kapalno steklenico shranjujte tesno zaprto v zunanji ovojnini za zagotovitev zaščite pred svetlobo.
English: Keep the dropper bottle tightly closed in the outer carton in order to protect from light.
Slovenian: Kapalno steklenico shranjujte tesno zaprto v zunanji ovojnini za zagotovitev zaščite pred svetlobo.
English: Similarly to other topically administered ocular products, systemic absorption is likely to occur.
Slovenian: Sistemska absorpcija je verjetna podobno kot pri drugih lokalno uporabljenih okularnih zdravilih.
English: Recordati Rare Diseases Immeuble "Le Wilson" 70, avenue du Général de Gaulle FR-92800 Puteaux France
Slovenian: Recordati Rare Diseases Immeuble “Le Wilson” 70, avenue du Général de Gaulle F - 92800 Puteaux Francija
English: Overdose is unlikely to occur with ocular administration.
Slovenian: Preveliko odmerjanje pri okularni uporabi ni verjetno.
English: What Cystadrops is
Slovenian: Kaj je zdravilo Cystadrops
English: Eye drops solution 1 vial of 5 mL
Slovenian: 1 viala s 5 ml
English: How to store Cystadrops
Slovenian: Shranjevanje zdravila Cystadrops
English: Cystadrops 3.8 mg/mL eye drops solution cysteamine (mercaptamine)
Slovenian: Cystadrops 3,8 mg/ml kapljice za oko, raztopina cisteamin (merkaptamin)
English: Ocular use.
Slovenian: okularna uporaba
English: • eye redness, eye itching, eye irritation (burning)
Slovenian: • pordelost oči, srbenje v očeh, draženje oči (pekoč občutek),
English: • visual impairement
Slovenian: • zamegljen vid,
English: Cystadrops 3.8 mg/mL eye drops solution cysteamine
Slovenian: Cystadrops 3,8 mg/ml kapljice za oko, raztopina cisteamin
English: Eye drops solution.
Slovenian: kapljice za oko, raztopina
English: • swollen eyelid
Slovenian: Γαλλία
English: Eye ointments should be administered last.
Slovenian: Očesna mazila uporabimo zadnja.
English: • watery eyes
Slovenian: • otekle veke,
English: Cystadrops 3.8 mg/mL eye drops solution
Slovenian: Cystadrops 3,8 mg/ml kapljice za oko, raztopina
English: • Bring the dropper bottle tip close to the eye. Use the mirror if it helps.
Slovenian: • Konico kapalne steklenice približajte očesu.
English: Administer eye ointments last.
Slovenian: Očesna mazila uporabite zadnja.
English: It must then be removed by a doctor or nurse.
Slovenian: Tedaj ga mora zdravnik ali medicinska sestra odstraniti.
English: It is a well-known substance, which has been used to control pain for many years.
Slovenian: Gre za dobro znano snov, ki se že leta uporablja za nadzor bolečin.
English: Medicinal product no longer authorise©EMEA 2008
Slovenian: Zdravilo nima veā dovoljenja za prome©EMEA 2008
English: Four main studies were performed in about 800 patients after an operation.
Slovenian: Izvedene so bile štiri glavne študije s približno 800 bolniki, ki so prestali operacijo.
English: The system will stop working 24 hours after the first dose or after 80 doses have been delivered.
Slovenian: Sistem bo prenehal delovati 24 ur po prvem odmerku ali po prejemu 80 odmerkov.
English: The European Commission granted a marketing authorisation valid throughout the European Union for IONSYS to Janssen-Cilag International NV on 24 January 2006.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom IONSYS, veljavno po vsej Evropski uniji, odobrila družbi Janssen-Cilag International NV dne 24. januarja 2006.
English: Other information about IONSYS:
Slovenian: Druge informacije o zdravilu IONSYS:
English: It is given using a system that is operated by the patient.
Slovenian: Daje se s pomočjo sistema, ki ga upravlja bolnik sam.
English: Fentanyl is derived from opium.
Slovenian: Fentanil se pridobiva iz opija.
English: IONSYS can be used up to six times in one hour, but for no more than 80 doses within a 24-hour period.
Slovenian: Zdravilo IONSYS se lahko uporabi največ šestkrat na uro, skupno število odmerkov pa ne sme biti več kot 80 odmerkov v 24-urnem obdobju.
English: The effects of IONSYS were first tested in experimental models before being studied in humans.
Slovenian: Učinki zdravila IONSYS so bili najprej preizkušeni na poskusnih modelih, nato pa so jih raziskali pri ljudeh.
English: Which measures are being taken to ensure the safe use of IONSYS?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne uporabe zdravila IONSYS?
English: The company that makes IONSYS will monitor the key safety risks associated with IONSYS such as overdose, abuse, addiction or misuse, and will provide an educational plan for patients, doctors and healthcare providers, aimed at minimising the risk and supporting the safe and effective use of the medicine.
Slovenian: Družba, ki proizvaja zdravilo IONSYS, bo nadzorovala glavna varnostna tveganja, povezana z zdravilom IONSYS, kot so preveliko odmerjanje, zloraba, odvisnost ali napačna uporaba, ter zagotovila izobraževalni načrt za bolnike, zdravnike in zdravstvene negovalce, katerega namen bo zmanjšanje tveganj in spodbujanje varne in učinkovite uporabe zdravila.
English: EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR) IONSYS EPAR summary for the public
Slovenian: EVROPSKO JAVNO POROČILO O OCENI ZDRAVILA (EPAR) IONSYS Povzetek EPAR za javnost
English: A doctor or a nurse applies the transdermal system to the patient's skin on the chest or upper arm.
Slovenian: Zdravnik ali medicinska sestra namestita transdermalni sistem na bolnikovo kožo na prsih ali nadlahti.
English: IONSYS must only be used in hospital, and it must not be used in patients who have respiratory problems (such as breathing difficulties), or heart, liver or kidney problems.
Slovenian: Zdravilo IONSYS se lahko uporablja samo v bolnišnicah in se ga ne sme uporabljati pri bolnikih, ki imajo dihalne motnje (kot npr. težave z dihanjem) ali težave s srcem, jetri ali ledvicami.
English: The Committee recommended that IONSYS be given marketing authorisation.
Slovenian: Odbor je priporočil podelitev dovoljenja za promet z zdravilom IONSYS.
English: The results of the study comparing IONSYS with morphine were insufficient to determine whether the two medicines were of similar effectiveness in relieving pain or not.
Slovenian: Rezultati študije, v kateri so zdravilo IONSYS primerjali z morfijem, niso zadostovali za presojo, ali sta obe zdravili podobno učinkoviti pri lajšanju bolečin ali ne.
English: These studies measured the number of patients who stopped treatment because they were not getting enough pain relief.
Slovenian: V teh študijah so beležili število bolnikov, ki so prenehali z zdravljenjem, ker jim slednje ni zadostno olajšalo bolečin.
English: The most common side effects with IONSYS (seen in more than 1 patient in 10) are nausea (feeling sick), vomiting, headache and erythema (redness of the skin) at the site of application.
Slovenian: Najpogostejši neželeni učinki zdravila IONSYS (opaženi pri več kot 1 bolniku izmed 10) so navzeja (občutek slabosti), bruhanje, glavobol in eritem (pordelost kože) na mestu uporabe zdravila.
English: The Committee for Medicinal Products for Human Use (CHMP) concluded that IONSYS offers potential benefits compared to systems where the pain relief is given via a vein: it is non-invasive, needle-free and pre-programmed, and it can be activated by the patient.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) je zaključil, da zdravilo IONSYS ponuja potencialne koristi v primerjavi s sistemi, v katerih se sredstvo za lajšanje bolečine daje preko vene: je namreč neinvaziven, ne zahteva uporabe igle, je predprogramiran in ga lahko sproža bolnik sam.
English: What benefit has IONSYS shown during the studies?
Slovenian: Kakšne koristi je zdravilo IONSYS izkazalo med raziskavami?
English: IONSYS is given to the patient after an operation.
Slovenian: Zdravilo IONSYS se daje bolnikom po operaciji.
English: These results show that IONSYS has a benefit in controlling pain after an operation.
Slovenian: Ti rezultati kažejo, da je zdravilo IONSYS koristno za nadzor bolečine po operaciji.
English: In three of them, IONSYS was compared with placebo (a transdermal system identical to IONSYS, but from which the medicine could not be released).
Slovenian: V treh študijah so zdravilo IONSYS primerjali s placebom (enakim transdermalnim sistemom, kot je IONSYS, iz katerega pa se zdravilo ni sproščalo).
English: In the studies where IONSYS was compared to placebo, the proportion of patients who stopped treatment because their pain was not controlled was lower in patients treated with IONSYS than those treated with placebo.
Slovenian: V študijah, v katerih so zdravilo IONSYS primerjali s placebom, je bil delež bolnikov, ki so prekinili z zdravljenjem, ker bolečina ni bila zadostno olajšana, manjši pri bolnikih, zdravljenih z zdravilom IONSYS, kot pri bolnikih, zdravljenih s placebom.
English: Once in the bloodstream, fentanyl acts on receptors in the brain and spinal cord to prevent pain.
Slovenian: Ko fentanil prispe v krvni obtok, začne delovati na receptorje v možganih in hrbtenjači in tako preprečuje bolečino.
English: What is the risk associated with IONSYS?
Slovenian: Kakšna tveganja so povezana z zdravilom IONSYS?
English: When in pain, the patient uses a button on the IONSYS system to start the delivery of a dose of fentanyl (40 micrograms).
Slovenian: Če bolnik začuti bolečino, pritisne stikalo na sistemu IONSYS, s čimer sproži dovajanje odmerka fentanila (40 mikrogramov).
English: For the full list of all side effects reported with IONSYS, see the Package Leaflet.
Slovenian: Za celoten seznam neželenih učinkov, o katerih so poročali pri uporabi zdravila IONSYS, glejte Navodilo za uporabo.
English: Therefore, the Committee decided that IONSYS's benefits are greater than its risks for the management of acute moderate to severe post-operative pain for use in a hospital setting only.
Slovenian: Odbor je zato odločil, da so koristi zdravila IONSYS pri nadzorovanju akutne zmerne do hude pooperativne bolečine pri njegovi uporabi samo v bolnišnicah večje od z njim povezanih tveganj.
English: Why has IONSYS been approved?
Slovenian: Zakaj je bilo zdravilo IONSYS odobreno?
English: When the patient activates IONSYS, a small electrical current moves a dose of fentanyl from the reservoir through the skin and into the bloodstream.
Slovenian: Ko bolnik aktivira sistem IONSYS, električni tok premakne odmerek fentanila iz rezervoarja skozi kožo v krvni obtok.
English: The fentanyl is contained inside a reservoir.
Slovenian: Fentanil se nahaja v rezervoarju.
English: However, the risk with IONSYS is low, as the medicine is for short-term use.
Slovenian: Ker pa je zdravilo IONSYS indicirano za kratkotrajno uporabo, je tveganje majhno.
English: IONSYS is an iontophoretic transdermal system (ITS), which delivers the active substance, fentanyl hydrochloride, into the body through the skin.
Slovenian: Zdravilo IONSYS je iontoforetični transdermalni sistem (ITS), ki skozi kožo v telo dovaja zdravilno učinkovino fentanilijev klorid.
English: IONSYS contain the active ingredient fentanyl, which is a strong painkiller.
Slovenian: Zdravilo IONSYS vsebuje zdravilno učinkovino fentanil, ki je močno sredstvo za lajšanje bolečin.
English: IONSYS is used to control pain after an operation, in patients who are in hospital.
Slovenian: Zdravilo IONSYS se uporablja za nadzor bolečine po operacijah in je namenjen samo uporabi v bolnišnicah.
English: The full EPAR for IONSYS can be found here.
Slovenian: Celotno Evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo IONSYS je na voljo tukaj.
English: Fentanyl, the active substance in IONSYS, can be abused.
Slovenian: Zdravilna učinkovina v zdravilu IONSYS je fentanil, ki ga je možno zlorabiti.
English: How has IONSYS been studied?
Slovenian: Kako je bilo zdravilo IONSYS raziskano?
English: How does IONSYS work?
Slovenian: Kako zdravilo IONSYS deluje?
English: What is IONSYS used for?
Slovenian: Za kaj se zdravilo IONSYS uporablja?
English: What is IONSYS?
Slovenian: Kaj je zdravilo IONSYS?
English: The fourth study compared IONSYS to morphine given by injection into a vein, and looked at the number of patients who judged their pain relief as ‘good' or ‘excellent'.
Slovenian: V tej študiji so beležili število bolnikov, ki so stopnjo olajšanja bolečine označili kot „dobro“ ali „odlično“.
English: How is IONSYS used?
Slovenian: Kako se zdravilo IONSYS uporablja?
English: 1 bottle + 1 syringe + 1 bottle adapter
Slovenian: 1 plastenka + 1 brizga + 1 nastavek
English: 20 mg/ml
Slovenian: 20 mg/ml peroralna raztopina
English: Date of first authorisation: 19 March 2002 Date of latest renewal: 21 February 2012
Slovenian: Datum prve odobritve: 19. marec 2002 Datum zadnjega podaljšanja: 21. februar 2012
English: * This also applies to patients aged 15 years and older
Slovenian: * To se nanaša tudi na bolnike, stare 15 let in več.
English: • you have had an allergic reaction to other azoles.
Slovenian: • ste kdaj doživeli alergijsko reakcijo na druge azole.
English: Clinical experience Successful outcome in this section is defined as complete or partial response.
Slovenian: Klinične izkušnje Uspešen izid je v tem delu opredeljen kot popoln ali delen odziv.
English: • Tablets must only be given if the child is able to swallow tablets.
Slovenian: • Tablete se sme uporabiti le, če jih je otrok sposoben pogoltniti.
English: The asterisk (*) indicates a twoway interaction.
Slovenian: Zvezdica (*) označuje dvosmerno interakcijo.
English: Do not stop treatment early because your infection may not be cured.
Slovenian: Zdravljenja ne končajte predčasno, ker vaša okužba morda še ni ozdravljena.
English: Località Marino del Tronto 63100 Ascoli Piceno (AP) Italy
Slovenian: Località Marino del Tronto 63100 Ascoli Piceno (AP) Italija
English: You should always add a total of 46 ml of water irrespective of the dose you are taking.
Slovenian: Vedno morate dodati vseh 46 ml vode, ne glede na odmerek, ki ga jemljete.
English: Repeat step 3 again.
Slovenian: Ponovite 3. korak.
English: In this analysis a successful response was seen in 41% of patients in both treatment arms.
Slovenian: V tej analizi so uspešen odziv ugotovili pri 41 % bolnikov v obeh terapevtskih krakih.
English: Four additional patients with fusariosis had an infection caused by several organisms; 2 of them had a successful outcome.
Slovenian: Dodatni štirje bolniki s fuzaridiozo so imeli okužbo, povzročeno z več organizmi; 2 od njih sta doživela uspešen izid.
English: • Existing symptomatic arrhythmias.
Slovenian: • obstoječe simptomatske aritmije,
English: The syringe should be washed after each dose.
Slovenian: Brizgo morate oprati po vsakem odmerku.
English: The following instructions apply to both Treatment and Prophylaxis
Slovenian: Naslednja navodila veljajo tako za zdravljenje kot tudi za profilakso
English: While affected, do not drive or operate any tools or machines.
Slovenian: Dokler to traja, ne smete voziti ali upravljati z orodji ali stroji.
English: Maximum increase in prothrombin time was approximately 2-fold.
Slovenian: Največje podaljšanje protrombinskega časa je bilo približno 2-kratno.
English: It is important to take your VFEND tablets regularly at the same time each day.
Slovenian: Pomembno je, da tablete VFEND jemljete redno, vsak dan ob istem času.
English: The contents of the infusion bag are now ready for infusion to the patient.
Slovenian: Vsebina infuzijske vrečke je sedaj pripravljena za infundiranje bolniku.
English: It is important to take your VFEND suspension regularly at the same time each day.
Slovenian: Pomembno je, da VFEND suspenzijo jemljete redno, vsak dan ob istem času.
English: Your treatment will be started as an infusion
Slovenian: zdravljenje se bo začelo v obliki infuzije
English: Frequency categories are expressed as: Very common (1/10); Common (1/100 to 1/10); Uncommon (1/1,000 to 1/100); Rare (1/10,000 to 1/1,000); Very rare (1/10,000); Not known (cannot be estimated from the available data).
Slovenian: Pogostnosti neželenih učinkov so opredeljene kot sledi: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000 do < 1/1.000), zelo redki (< 1/10.000), neznana (ni mogoče oceniti iz razpoložljivih podatkov).
English: • Sinus bradycardia.
Slovenian: • sinusna bradikardija,
English: Each kit is for single use only.
Slovenian: Vsak komplet je le za enkratno uporabo.
English: This study confirmed findings from an earlier, prospectively designed study where there was a positive outcome in subjects with risk factors for a poor prognosis, including graft versus host disease, and, in particular, cerebral infections (normally associated with almost 100% mortality).
Slovenian: Ta študija je potrdila izsledke zgodnejše, prospektivne študije, v kateri so ugotovili pozitiven izid pri preskušancih z dejavniki tveganja za slabo prognozo, vključno z boleznijo presadka proti gostitelju in, še posebej, možganskimi okužbami (ki so običajno povezane s skoraj 100 % umrljivostjo).
English: For example, 15-20% of Asian populations may be expected to be poor metabolisers.
Slovenian: Tako je na primer mogoče pričakovati, da ima od 15 do 20 % azijske populacije zmanjšano presnovo.